Telavant Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 19

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Telavant General Information

Description

Developer of innovative drugs and therapies intended to serve patients living with inflammatory and fibrotic diseases. The company is engaged in developing subcutaneous therapy for ulcerative colitis and Crohn's disease, including for patients with a prospectively defined biomarker who may benefit from a precision approach.

Contact Information

Website
www.telavanttx.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 151 West 42nd Street
  • 15th Floor
  • New York, NY 10036
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Roche
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 151 West 42nd Street
  • 15th Floor
  • New York, NY 10036
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Telavant Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Telavant‘s full profile, request access.

Request a free trial

Telavant Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of innovative drugs and therapies intended to serve patients living with inflammatory and fibrotic diseases. T
Drug Discovery
New York, NY
19 As of 2023

Melbourne, Australia

Antwerp, Belgium
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Telavant Competitors (5)

One of Telavant’s 5 competitors is Certa Therapeutics, a Venture Capital-Backed company based in Melbourne, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Certa Therapeutics Venture Capital-Backed Melbourne, Australia
Agomab Therapeutics Formerly VC-backed Antwerp, Belgium
Abcentra Venture Capital-Backed Los Angeles, CA
Damora Therapeutics ( Drug Discovery) Formerly VC-backed Waltham, MA
Tvardi Therapeutics Formerly VC-backed Sugar Land, TX
You’re viewing 5 of 5 competitors. Get the full list »

Telavant Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Telavant Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Telavant‘s full profile, request access.

Request a free trial

Telavant FAQs

  • When was Telavant founded?

    Telavant was founded in 2022.

  • Where is Telavant headquartered?

    Telavant is headquartered in New York, NY.

  • What is the size of Telavant?

    Telavant has 19 total employees.

  • What industry is Telavant in?

    Telavant’s primary industry is Drug Discovery.

  • Is Telavant a private or public company?

    Telavant is a Private company.

  • What is the current valuation of Telavant?

    The current valuation of Telavant is .

  • What is Telavant’s current revenue?

    The current revenue for Telavant is .

  • Who are Telavant’s investors?

    Pfizer and Roivant Sciences have invested in Telavant.

  • Who are Telavant’s competitors?

    Certa Therapeutics, Agomab Therapeutics, Abcentra, Damora Therapeutics ( Drug Discovery), and Tvardi Therapeutics are competitors of Telavant.

  • When was Telavant acquired?

    Telavant was acquired on 14-Dec-2023.

  • Who acquired Telavant?

    Telavant was acquired by Roche.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process